Skip to content

Clinical study of lung protection in patients with acute lung injury

Clinical study of lung protection in patients with acute lung injury

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-17010954
Enrollment
Unknown
Registered
2017-03-22
Start date
2016-03-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute lung injury

Interventions

Adults Control group:adminster the saline in the same manner as dextomedetomidine in Group B
Adults Dextomedetomidine group:A bolus dose of dexmedetomidine with 1.0ug/kg for 15 min before the induction of anesthesia then continued infusion at 0.5 ug/kg/h until the end of the surgery
Children Control group:adminster the saline in the same manner as dextomedetomidine in Group D
Children Dextomedetomidine group:A bolus dose of dexmedetomidine with 1.0ug/kg for 15 min before the induction of anesthesia then continued infusion at 0.5 ug/kg/h until the end of the surgery

Sponsors

Affiliated Hospital of Zunyi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. aged 1 to 65 years; 2. American Society of Anaesthesiologists physical status from 1 to 3; 3. Expected duration of surgery undergoing General anesthesia shorter than at least 5 hour; 4. Local is less than 2500 meters above sea level.

Exclusion criteria

Exclusion criteria: 1. medication with anticoagulants within the previous less than 3 days; 2. Redo heart surgery; 3. Severe heamatological diseases and endocrine system diseases; 4. Severe arrhythmia; 5. with renal insufficiency or Liver dysfunction or pre-operative coagulation disorders; 6. pulmonary disease,such as pulmonary hypertensionchronic bronchitis or pulmonary infectious diseases; 7. Heparin-resistant, heparin-induced thrombocytopenia syndrome; 8. Cardiac resuscitation is difficult(defibrillation>4 times); 9. Surgery undergoing General anesthesia longer than at least 5 hour; 10. Chronic heart failure or tetralogy of Fallo (TOF).

Design outcomes

Primary

MeasureTime frame
Hemodynamics;IL-6;IL-8;ICOM-1;TNFalpha;Cortisol;Norepinephrine;Adrenaline;

Countries

China

Contacts

Public ContactZhang Hong

Affiliated Hospital of Zunyi Medical University

1789520047@qq.com+86 18685630890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 27, 2026